Tag: objectives

– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant –

Dallas, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Digital Wealth Partners Management, LLC (“DWP Management”), the general partner behind a series of private investment vehicles accepting in-kind digital asset contributions, announced today it has called approximately $200 million in capital across its fund strategies since April. To date, all in-kind contributions have been made in XRP.

MONTREAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Company”) (TSX: BLX) announces the appointment of Mr. André Courville as Chair of the Board of Directors. He will officially succeed Mr. Alain Rhéaume on September 30, following Mr. Rhéaume’s retirement announced last June after 15 years of service on the Board, including eight as Chair.

MONTREAL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Boralex Inc. (“Boralex” or the “Corporation”) (TSX: BLX) is pleased to report its results for the second quarter of 2025.

CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) -- FLINT Corp. ("FLINT" or the "Company") (TSX: FLNT) is pleased to announce a proposed recapitalization transaction (the "Recapitalization") that will significantly reduce the Company's debt and annual interest costs, simplify its capital structure and improve liquidity. The Recapitalization is the result of an extensive review process conducted by the Company's board of directors (the "Board"), which culminated in FLINT entering into a definitive recapitalization support agreement (the "Support Agreement") with its largest shareholder and primary lender, Canso Investment Counsel Ltd., in its capacity as portfolio manager for and on behalf of certain accounts that it manages ("Canso"). The Recapitalization is intended to preserve value for the Company's shareholders and better position FLINT to execute on future growth opportunities.